$ARRY

LEN, ARRY Stocks Hit New Lows As Price Target Cuts Pile Up — What’s Driving The Selloff?

Array Technologies (ARRY) and Lennar (LEN) shares fell to multi-year lows. UBS cut ARRY's target to $5, citing cash flow concerns. Barclays, BTIG, and RBC lowered LEN's targets, citing weak margins and revenue misses. Both stocks saw bearish retail sentiment.

Original reporting
Published Sep 18, 2026, 6:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 7:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LEN, ARRY Stocks Hit New Lows As Price Target Cuts Pile Up — What’s Driving The Selloff? — source image
Decision brief

The 30-second read

$ARRYBearishMed
01

Why it matters

Both firms face near‑term price pressure; traders may consider short positions or avoid new long exposure.

02

Market read

The news provides fresh actionable data on two large‑cap U.S. stocks, affecting sector sentiment.

03

What to watch

Potential cost‑saving measures or new project pipelines for LEN may mitigate margin pressure.

Relevance 7/10Novelty 7/10Timing: Friday

Background

Analyst downgrades and earnings miss drive fresh negative sentiment for both companies.

Company-level read

Ticker impact

$ARRYBearishHigh confidence
Context

UBS downgraded Array Technologies to Neutral and cut its price target to $5, citing new cash‑flow‑draining preferred dividend payments.

Expected impact

Further downside pressure in near‑term trading.

Evidence & confidence

Downgrade with 50% target reduction and cash‑flow concerns are material for a 7% price drop.

$LENBearishHigh confidence
Context

Lennar reported Q3 revenue of $8.04 B and EPS of $1.23, both missing estimates, prompting multiple analysts to cut price targets.

Expected impact

Potential further decline as investors reassess margins.

Evidence & confidence

Revenue miss and three analyst target reductions signal weakening fundamentals.

Market effects

Homebuilding and solar‑panel sectors face heightened scrutiny after earnings misses and dividend‑policy concerns.

U.S. markets may see broader weakness in construction‑related stocks.

Limited to U.S. equities; no direct global macro impact.

Counterpoint

If the dividend policy change stabilizes cash flow, ARRY could rebound on longer‑term growth prospects.

Key entities

  • UBS

    Downgraded ARRY and cut its price target.

  • Barclays

    Reduced LEN price target to $70.

Related articles

$LENHigh

Fitch shifts Lennar outlook to negative on margin compression and demand risks

Fitch Ratings changed Lennar's outlook to negative from stable, citing margin compression and demand risks in the U.S. housing market. The agency expects Lennar's EBITDA margins to fall to 5.5%-6.5% in 2026, down from 8.4% in 2025, with revenues declining 6%-7% due to affordability challenges and weak consumer confidence. Despite near-term headwinds, Lennar's scale and capital-efficient model provide downside protection.

$LENMed

LEN Maintains Rating -- Price Target Lowered to $75.00 by Wells

Wells Fargo maintained an Equal-Weight rating on Lennar (LEN) but lowered its price target from $80 to $75, citing potential headwinds in the homebuilding sector. Lennar's GF Value™ is $123.73, suggesting a 38.7% undervaluation at its current price of $75.90. The company has a GF Score™ of 71, indicating solid financial health and profitability, but limited growth prospects. Insider buying totaled $589.6 million over the last three months.

$LENMed

The Second Biggest Homebuilder Gets a Berkshire Hathaway Boost - Lennar (NYSE:LEN)

Lennar (LEN) shares rose in premarket trading after Berkshire Hathaway (BRK) disclosed additional purchases, totaling 2.42 million shares at an average price of $79.65. Lennar, the second-largest U.S. homebuilder, faces housing-market weakness, analyst skepticism, and allegations involving its Millrose spinoff. Management has cited labor shortages, affordability constraints, and higher costs as challenges. Analysts maintain a Sell consensus rating with an average price target of $76.18.